PRESS RELEASES & NEWS

PRESS RELEASES

VICTUS® Femtosecond Laser Platform Receives CE Mark for Corneal Incisions, Penetrating Keratoplasty and Intrastromal Channel Incisions for Intracorneal Ring Segments

VICTUS™ Femtosecond Laser Platform from Bausch + Lomb Technolas Receives 510(k) Clearance from FDA for Arcuate Incision Procedure

Bausch + Lomb Completes Acquisition of Technolas Perfect Vision GmbH

Bausch + Lomb to Acquire Technolas Perfect Vision GmbH

B+L and TPV Receive 510(k) FDA Clearance from FDA for VICTUS™ Femtosecond Laser Platform

TPV Innovator Receives Prestigious European Inventor Award

TPV announces new Canadian distributor agreement with Sigmacon Ophthalmic

Bausch + Lomb and Technolas Perfect Vision Announce CE Mark Approval for VICTUS™ Femtosecond Laser Platform

Bausch + Lomb and Technolas™ Perfect Vision Introduce VICTUS™ Femtosecond Laser Platform at 2011 ESCRS Meeting

HIGH SPEED SESSION MANAGEMENT adds Efficiency to Reliability on the TECHNOLAS® Excimer Workstation 217P

Bausch + Lomb Enters Into Definitive Agreement with Technolas Perfect Vision GmbH Acquiring An Option to Purchase Company

Prof Auffarth performs first femto-cataract CUSTOMLENS procedure in Germany- PR courtesy of Heidelberg University Hospital (English translation below German press release)

TPV’s New SUPRACOR™ Presbyopia Treatment Receives CE Mark Approval

TPV showcasing new all laser femtoscond laser cataract and refractive system at the ASCRS

PV Reports Double Digit Growth in US LASIK Procedures

TPV Receives FDA Approval of Latest Technology for Custom LASIK

TPV to present at 29th Annual J.P. Morgan Healthcare Conference

Technolas Perfect Vision unveils two new pioneering laser procedure innovations at the XXVIII Congress of the ESCRS, Paris

ACE US Adoption

TPV Announces Issuance of Two Foundation Patents

ACE US Approva
Latest Advance in LASIK Eye Surgery Approved by the US Food and Drug Administration


Bausch & Lomb and 20/10 Perfect Vision Finalize Refractive Surgery Joint Venture
INTRACOR now carries CE Mark for the treatment of presbyopic hyperopes


Some of the products and/or specific features as well as the procedures featured on this website may not be approved in your country and thus may not be available there. The VICTUS platform has CE Marking for capsulotomy, lens fragmentation, arcuate corneal incisions, corneal incisions, LASIK flap, INTRACOR®, penetrating keratoplasty and intrastromal channel incisions for intracorneal ring segments. Indications may vary by country. The VICTUS platform is cleared in the United States for creation of a corneal flap in patients undergoing LASIK surgery or other treatment requiring initial lamellar resection of the cornea, anterior capsulotomy during cataract surgery, and arcuate incisions during cataract surgery.
SUPRACOR, INTRACOR, and CUSTOMSHAPE are CE marked but NOT approved for use in the US.
INTRACOR, SUPRACOR, CUSTOMSHAPE and CUSTOMFLAP are not approved in all countries. Please contact our regional representative regarding individual availability in your respective market.
CAREERS | IMPRINT & LEGAL STATEMENTS

© 2012-2013 TECHNOLAS Perfect Vision GmbH. All Rights Reserved
A Bausch + Lomb Company
powered by DASAT